Fynzur

Fynzur is a hair-loss treatment brand focused on topical finasteride for men with androgenetic alopecia. Its featured product, Fynzur 2.275 mg/ml spray solution, is applied to the scalp and contains finasteride. The brand describes the treatment as providing targeted action at the center of the hair bulb. Product information includes the Summary of Product Characteristics (SmPC), which identifies the medicine as a cutaneous spray solution for scalp use and provides prescribing and safety details.

Fynzur also presents information about the product’s efficacy and safety, including a phase III randomized controlled clinical trial of topical finasteride spray solution for male androgenetic alopecia. The cited study by M. Piraccini, U. Blume-Peytavi and colleagues was published in the Journal of the European Academy of Dermatology and Venereology in February 2022. The website offers sections covering the product, efficacy and safety, news, and contact information, alongside legal and privacy notices. Its content is centered on explaining the treatment and directing visitors to relevant product and clinical information.